Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Pancreatic Ductal Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04580485
What this trial is testing

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

Who this might be right for
Ovarian CancerBladder CancerNon Small Cell Lung Cancer+8 more
Incyte Corporation 54
Testing effectiveness (Phase 2)Looking for participantsNCT06850623
What this trial is testing

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
EXACT Therapeutics AS 25
Testing effectiveness (Phase 2)Looking for participantsNCT07114861
What this trial is testing

The KN510713 Study in Combination With mFOLFIRINOX

Who this might be right for
Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
New Cancer Cure-Bio Co.,Ltd. 30
Early research (Phase 1)Study completedNCT04672434
What this trial is testing

Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 48
Testing effectiveness (Phase 2)UnknownNCT03221400
What this trial is testing

PEN-866 in Patients With Advanced Solid Malignancies

Who this might be right for
CarcinomaEndometrial AdenocarcinomaNeoplasms+16 more
Tarveda Therapeutics 340
Early research (Phase 1)Study completedNCT04943900
What this trial is testing

BMS-986416 With and Without Nivolumab in Select Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 67
Early research (Phase 1)Study completedNCT05546853
What this trial is testing

Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
University Hospital, Grenoble 43
Early research (Phase 1)Active Not RecruitingNCT05607953
What this trial is testing

Pressure Enabled Intrapancreatic Delivery of SD-101 With Checkpoint Blockade for Locally Advanced Pancreatic Adenocarcinoma

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
TriSalus Life Sciences, Inc. 60
Testing effectiveness (Phase 2)Looking for participantsNCT07483983
What this trial is testing

Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance

Who this might be right for
Metastatic/Locally Advanced Non-Small-Cell Lung CancerMetastatic/Locally Pancreatic Ductal Adenocarcinoma
Gustave Roussy, Cancer Campus, Grand Paris 60
Testing effectiveness (Phase 2)WithdrawnNCT03432676
What this trial is testing

Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic Cancer

Who this might be right for
ATM Gene MutationDeleterious BRCA1 Gene MutationDeleterious BRCA2 Gene Mutation+7 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01547260
What this trial is testing

Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma MetastaticPancreatic Ductal Adenocarcinoma
Maria Liljefors 34
Not applicableLooking for participantsNCT05630989
What this trial is testing

A Registry to Capture Patient Outcomes With KRAS G12R Altered Advanced Pancreatic Ductal Adenocarcinoma Treated With MEK Inhibitor-based Combination Therapy

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Mandana Kamgar, MD 80
Not applicableEnded earlyNCT04476537
What this trial is testing

RNA Precision Oncology in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Columbia University 16
Early research (Phase 1)Looking for participantsNCT06458712
What this trial is testing

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

Who this might be right for
Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency)
Duke Street Bio Ltd 180
Testing effectiveness (Phase 2)UnknownNCT06467565
What this trial is testing

NALIRIFOX as Induction Therapy in LAPC

Who this might be right for
Pancreatic Ductal Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05945823
What this trial is testing

Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

Who this might be right for
Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal CancerEsophageal AdenocarcinomaEsophageal Squamous Cell Cancer+2 more
Taiho Oncology, Inc. 53
Large-scale testing (Phase 3)Active Not RecruitingNCT06783140
What this trial is testing

Study of NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Advanced or MetastaticBRCA1/2 MutationPALB2 Gene Mutation
University Health Network, Toronto 10
Not applicableStudy completedNCT03257150
What this trial is testing

The Use of Irreversible Electroporation in Pancreatic Ductal Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
University Health Network, Toronto 12
Testing effectiveness (Phase 2)WithdrawnNCT04134468
What this trial is testing

MRI Effects of Pegvorhyaluronidase Alfa (PEGPH20) in Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Abramson Cancer Center at Penn Medicine
Early research (Phase 1)Looking for participantsNCT04900818
What this trial is testing

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorAdvanced CancerMetastatic Cancer+5 more
I-Mab Biopharma US Limited 330
Next Page